Hainan Shuangcheng Pharmaceuticals Co., Ltd.

About Hainan Shuangcheng Pharmaceuticals Co., Ltd.

HNSP was founded in 2000 and is a publicly-traded company. We engage in development, manufacturing and marketing of both APls and drug products. We have more than 10 management members with oversea doctor degree and also oversea experience in R&D, manufacture and/or registration. HNSP enjoys a strong team of regulatory registration, and also a China-based sales force of over 400 agents. With excellent know-how in peptide chemistry, HNSP is a leader in the field of peptide manufacture in China.
Most of our facilities were built based on the EU and US CGMP standards.
HNSP has been inspected respectively by USFDA and (Italy) AIFA and the GMP status was considered acceptable and spoken highly of.
Our Thymalfasin API and FDF has also been approved by (Italy) AIFA.We are open to discuss any forms of collaborations.

  • CN
  • 2015
    On CPHI since
Company types
Manufacturer/Innovator
Contact info

Products from Hainan Shuangcheng Pharmaceuticals Co., Ltd. (3)

  • Aciclovir for injection (0.25g)

    Product Aciclovir for injection (0.25g)

    Hainan Shuangcheng Pharmaceuticals Co. manufactures apis and generic finished dosage products which includes aciclovir for injection (0.25g). It belongs to finished dosages products category. Contact us for more information.
  • Adenosine cyclophosphate for injection (20mg)

    Product Adenosine cyclophosphate for injection (20mg)

    Hainan Shuangcheng Pharmaceuticals Co. manufactures apis and generic finished dosage products which includes adenosine cyclophosphate for injection (20mg). It belongs to finished dosages products category. Contact us for more information.
  • Azithromycin for injection (0.5g)

    Product Azithromycin for injection (0.5g)

    Hainan Shuangcheng Pharmaceuticals Co. manufactures apis and generic finished dosage products which includes azithromycin for injection (0.5g). It belongs to finished dosages products category. Contact us for more information.